JPH07502039A - 新規テトラヒドロナフタレン誘導体 - Google Patents

新規テトラヒドロナフタレン誘導体

Info

Publication number
JPH07502039A
JPH07502039A JP5510766A JP51076692A JPH07502039A JP H07502039 A JPH07502039 A JP H07502039A JP 5510766 A JP5510766 A JP 5510766A JP 51076692 A JP51076692 A JP 51076692A JP H07502039 A JPH07502039 A JP H07502039A
Authority
JP
Japan
Prior art keywords
general formula
group
formula
oxo
naphthyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5510766A
Other languages
English (en)
Japanese (ja)
Inventor
バロー,イルディコー
ドーバイ,ラースロー
エゼル,エレメール
フィシュチェル,ヤーノシュ
ハヨーシュ,ジュルジ
マトゥーズ,ユディト
マールバーニョシュ,エデ
サージィ,カタリン
スポルニュ,ラースロー
Original Assignee
リヒター ゲデオン ベジェセティ ジャール アール.テー.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by リヒター ゲデオン ベジェセティ ジャール アール.テー. filed Critical リヒター ゲデオン ベジェセティ ジャール アール.テー.
Publication of JPH07502039A publication Critical patent/JPH07502039A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP5510766A 1991-12-19 1992-12-18 新規テトラヒドロナフタレン誘導体 Pending JPH07502039A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU914021A HU209487B (en) 1991-12-19 1991-12-19 Process for producing tetrahydro-naphtaline derivatives and pharmaceutical compositions containing them as active agents
HU4021/91 1991-12-19
PCT/HU1992/000058 WO1993012070A1 (en) 1991-12-19 1992-12-18 New tetrahydronaphthalene derivatives

Publications (1)

Publication Number Publication Date
JPH07502039A true JPH07502039A (ja) 1995-03-02

Family

ID=10966554

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5510766A Pending JPH07502039A (ja) 1991-12-19 1992-12-18 新規テトラヒドロナフタレン誘導体

Country Status (12)

Country Link
EP (1) EP0618894A1 (enrdf_load_stackoverflow)
JP (1) JPH07502039A (enrdf_load_stackoverflow)
CN (1) CN1074213A (enrdf_load_stackoverflow)
CA (1) CA2126198A1 (enrdf_load_stackoverflow)
FI (1) FI942927A0 (enrdf_load_stackoverflow)
HU (1) HU209487B (enrdf_load_stackoverflow)
IL (1) IL104196A0 (enrdf_load_stackoverflow)
NO (1) NO942306L (enrdf_load_stackoverflow)
NZ (1) NZ245534A (enrdf_load_stackoverflow)
TW (1) TW223623B (enrdf_load_stackoverflow)
WO (1) WO1993012070A1 (enrdf_load_stackoverflow)
ZA (1) ZA929913B (enrdf_load_stackoverflow)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR37790B (el) * 1966-12-30 1969-07-15 F. Hoffmann - La Roche & Co. Aktiengesellschaft Μεθοδος δια την παρασκευην παραγωγων του αρουλακρυλικου οξεος.
HU198294B (en) * 1987-06-10 1989-09-28 Richter Gedeon Vegyeszet Process for producing butenoic acid amides and pharmaceutical compositions comprising such active ingredient
HU198446B (en) * 1987-09-25 1989-10-30 Richter Gedeon Vegyeszet Process for production of new amids of buten acid and medical compositions containing such active substances

Also Published As

Publication number Publication date
HU209487B (en) 1994-06-28
CN1074213A (zh) 1993-07-14
HU914021D0 (en) 1992-03-30
NO942306D0 (no) 1994-06-17
NO942306L (no) 1994-06-17
WO1993012070A1 (en) 1993-06-24
NZ245534A (en) 1995-07-26
EP0618894A1 (en) 1994-10-12
HUT63147A (en) 1993-07-28
FI942927A7 (fi) 1994-06-17
IL104196A0 (en) 1993-05-13
ZA929913B (en) 1993-06-24
FI942927A0 (fi) 1994-06-17
CA2126198A1 (en) 1993-06-24
TW223623B (enrdf_load_stackoverflow) 1994-05-11

Similar Documents

Publication Publication Date Title
JP2529172B2 (ja) アミノ酸から誘導される新規な光学異性体と、その製造方法と、その医薬への応用
DE69409525T2 (de) Acetamidderivate und ihre verwendung als modifizierungsmittel des verhaltens der verdauung
GB2048268A (en) Amides of acyl-carnitines process for preparing same and pharmaceutical compositions containing such amides
CA1130800A (en) N-SUBSTITUTED .omega.-AMINOALKANOYL-.omega.-AMINOALKANOIC ACIDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION AS WELL AS PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS
CA1101846A (en) Derivatives of 4-hydroxy-phenylglycine
JPS6229566A (ja) 新規グアニジノメチル安息香酸誘導体
JPH07502255A (ja) 抗ウイルス化合物類
JP2603639B2 (ja) チアゾリジン―4―カルボン酸化合物、その製造方法、この化合物を含有する解熱消炎鎮痛剤および虚血・リパーフュージョン症候群治療薬
KR100224330B1 (ko) 골관절 질환의 치료에 유용한 n-((4,5-디히드록시-및 4,5,8-트리히드록시-9,10-디히드로-9,10-디옥소-2-안트라센-일)카르보닐)아미노산
JPH07502039A (ja) 新規テトラヒドロナフタレン誘導体
DE2557145A1 (de) Tyrosinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
JP2567593B2 (ja) イミダゾリジントリオン誘導体及び該化合物を有効成分として含有するアレルギ−性疾患治療剤
CA1064932A (en) N-(4'-benzamido)-2-pyrrolidone-4-carboxylic acid compounds
US4912135A (en) Amide compounds
KR850001880B1 (ko) 트란스-4-[n-(3', 4'-메틸렌디옥시벤질리덴)아미노메틸] 사이클로헥산-1-카복실산 및 이의 유도체의 제조방법
KR940003292B1 (ko) 광학적 활성 2-메틸-1-(4-트리플루오로메틸페닐)-3-피롤리디노-1-프로파논 및 그 제조방법
JPS6324498B2 (enrdf_load_stackoverflow)
DE2559928C2 (de) N-Aroyl-L-phenylalanyl-L-tyrosine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
JP2589245B2 (ja) N−(3−アルキル(またはアルケニル)−4−ヒドロキシベンゾイル)グリシン亜鉛錯体
JPS6330462A (ja) 新規グアニジノメチルベンツアミド誘導体およびそれを有効成分とする抗潰瘍剤
US4342781A (en) Diphenylpropenamides as SRS-A antagonists
JPS5839150B2 (ja) リジノ−ル誘導体
JPH0139421B2 (enrdf_load_stackoverflow)
JPH01156942A (ja) 4−オキソ−4−(置換フェニル)ブテノイル−サリシレート
JPH01156949A (ja) 4−オキソ−4−(置換フェニル)ブテン酸アミド